Recursion Pharmaceuticals (NASDAQ: RXRX), and CRISPR Therapeutics (NASDAQ: CRSP), plunged in March, with the stocks down 35.3 ...
Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion ...
KLP Kapitalforvaltning AS acquired a new stake in Biohaven Ltd. (NYSE:BHVN – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 16,100 shares of the ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results